<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10538396</article-id><article-id pub-id-type="pmcid-ver">PMC10538396.319</article-id><article-id pub-id-type="pmcaid">10538396</article-id><article-id pub-id-type="pmcaiid">10538396</article-id><article-id pub-id-type="manuscript-id">NIHMS1928311</article-id><article-id pub-id-type="pmid">37598454</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2023.110923</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1928311</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1928311</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Longitudinal changes in neurocognitive performance related to drug use intensity in a sample of persons with and without HIV who use illicit stimulants</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Towe</surname><given-names initials="SL">Sheri L.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tang</surname><given-names initials="R">Runshi</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gibson</surname><given-names initials="MJ">Matthew J.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="AR">Anru R.</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meade</surname><given-names initials="CS">Christina S.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Duke University School of Medicine, Department of Psychiatry &amp; Behavioral Sciences, Durham, NC, 27708, USA</aff><aff id="A2"><label>b</label>University of Wisconsin-Madison, Department of Statistics, Madison, WI, 53706, USA</aff><aff id="A3"><label>c</label>Duke University School of Medicine, Department of Biostatistics &amp; Bioinformatics, Durham, NC, 27708, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold>Contributors:</bold> CSM conceptualized the study and secured grant funding as principal investigator. SLT drafted the manuscript, and CSM, RT, and ARZ contributed to writing and provided revisions. RT and ARZ performed data analysis. MG assisted in literature reviews and manuscript revisions. All authors contributed to interpretation of findings. All authors have read and approved the final manuscript.</p></fn><corresp id="CR1"><bold>Correspondence concerning this article should be addressed to:</bold> Sheri L. Towe, PhD, Duke University, Box 102848, Durham, NC 27710 USA, <email>sheri.towe@duke.edu</email>, tel. 919-668-4030</corresp><fn fn-type="COI-statement" id="FN4"><p id="P48"><bold>Conflict of Interest:</bold> All authors declared no conflict of interest.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>09</day><month>8</month><year>2023</year></pub-date><volume>251</volume><issue-id pub-id-type="pmc-issue-id">446205</issue-id><fpage>110923</fpage><lpage>110923</lpage><pub-history><event event-type="nihms-submitted"><date><day>01</day><month>09</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-01 00:25:29.690"><day>01</day><month>10</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1928311.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P2">Illicit stimulant use remains a public health concern that has been associated with multiple adverse outcomes, including cognitive deficits. The effects of stimulant use on cognition may be particularly deleterious in persons with HIV. Stimulant use intensity may be an important factor in the magnitude of observed deficits over time.</p></sec><sec id="S2"><title>Methods:</title><p id="P3">We completed neurocognitive testing in a sample of people who use stimulants with (n = 84) and without HIV (n = 123) at baseline and up to 4 follow-up time points over approximately 1 year. Participants reported on substance use at each visit, including frequency of use and stimulant dependence. Mixed effects models examined the relationship between stimulant-related factors and neurocognitive function over time.</p></sec><sec id="S3"><title>Results:</title><p id="P4">Participants were mostly male (57%), African American (86%), and 47.41 years old on average. All participants actively used stimulants at enrollment and use remained prevalent throughout the follow-up period, with an average of &#8805;24 days of use in the past 90 days at all time points. Retention was excellent, with 86% completing all 4 follow-up assessments. Mixed effects models showed that stimulant dependence was associated with lower neurocognitive performance independent of HIV status (p = 0.002), whereas frequency of use had a greater negative impact on performance in participants with HIV compared to those without HIV (p = 0.045).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P5">Our key finding is that stimulant-related factors are associated with neurocognitive performance over time, but in complex ways. These findings have important implications for harm reduction approaches, particularly those that target cognitive function.</p></sec></abstract><kwd-group><kwd>HIV/AIDS</kwd><kwd>cocaine dependence</kwd><kwd>drug abuse</kwd><kwd>neurocognitive impairment</kwd><kwd>HIV-associated neurocognitive disorders</kwd><kwd>neuropsychology</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>